Speaker List - 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference

5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference

8th - 9th February 2023 | Double Tree by Hilton, San Diego - Mission Valley
CONFERENCE SPEAKERS
Advisors
 Julius Goepp
Julius Goepp
Founder, CEO,
Scaled Microbiomics


Julius Goepp is the founder and CEO of Scaled Microbiomics, LLC, a pre-clinical stage biotech company focused on passive immunotherapy in the microbiome. Dr. Goepp trained in Pediatrics and Emergency Medicine at Children’s Hospital, Boston, and in Pediatric Infectious Disease at Johns Hopkins, where he was active in the promotion of Oral Rehydration Therapy for childhood diarrheal disease. In 2017, he founded Scaled Microbiomics after recognizing the potential for microbiome modulation through the use of little-known avian antibodies, or IgY. Since that time, his energies have been devoted to exploring the characteristics of those antibodies and developing a drug discovery platform based on their use as selective immunomodulators of complex microbiome signaling pathways and event cascades. In addition to his work, Goepp is passionate about cooking, flying, and exploring the outdoors.


 Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer,
Dakota Biotech


Maya Ivanjesku M.S. is a creative visionary, CSO and a formulation scientist at Dakota Biotech -The Live Probiotic Skincare company. With over 25 years of experience in developing products for the beauty industry, Maya is a formulation expert. Her career path started at Estee Lauder Companies where she was formulating products for Estee Lauder, Clinique, Origins, Bobby Brown, Aveda, LaMer etc. With her passion for science and nature, Maya also ventured into Biotech, OTC and topical Rx and Medical Device formulation and developed topical prescription formulas for numerous pharmaceutical companies. The diversity of her career path in formulating products, overseeing manufacturing, R&D and holding executive positions in numerous industries from cosmetic to pharmaceutical and biotech product launches, has lead Maya into an entrepreneurial opportunity at Dakota Biotech where LaFloreÒ Probiotic Skincare product line was born. Maya’s passion for wellness, education and helping people heal – naturally, is the main driver in developing performance focused products.


Peter Leighton
Peter Leighton
CEO,
ProSperity Bioscience


Peter Leighton is the CEO of ProSperity Bioscience, engaged in the development and marketing of functionally targeted probiotic consumer products. Leighton is also the founder of Abunda, an integrated consulting practice. His 30+ years of executive experience at the intersection of consumer products and life science technology has leveraged emerging scientific research & discovery into engaging consumer brands. He has identified and executed novel marketing & commercialization strategies leading to the successful development and launch of hundreds of new products. Leighton has been a guiding light to entrepreneurial enterprises and companies facing a challenge. In the early 2000’s he orchestrated a 300% increase in stock valuation and sales growth at Natrol (NTOL). Leighton has held senior executive positions including VP Product Strategy at Complete Nutrition, CEO at Advana Science, VP Marketing & Product Development at Natrol (NTOL), Vice President at Galileo Laboratories, VP Marketing at Metabolife, SVP Marketing at Weider Nutrition (WNI) and Director of Marketing at InterHealth Nutraceuticals.


Seth D. Crosby
Seth D. Crosby
Director, Research Collaborations,
Washington University School of Medicine



Arun K. Bhunia
Arun K. Bhunia
Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science,
Purdue Institute of Inflammation, Immunology and Infectious Disease



Speakers
 Julius Goepp
Julius Goepp
Founder, CEO,
Scaled Microbiomics


Julius Goepp is the founder and CEO of Scaled Microbiomics, LLC, a pre-clinical stage biotech company focused on passive immunotherapy in the microbiome. Dr. Goepp trained in Pediatrics and Emergency Medicine at Children’s Hospital, Boston, and in Pediatric Infectious Disease at Johns Hopkins, where he was active in the promotion of Oral Rehydration Therapy for childhood diarrheal disease. In 2017, he founded Scaled Microbiomics after recognizing the potential for microbiome modulation through the use of little-known avian antibodies, or IgY. Since that time, his energies have been devoted to exploring the characteristics of those antibodies and developing a drug discovery platform based on their use as selective immunomodulators of complex microbiome signaling pathways and event cascades. In addition to his work, Goepp is passionate about cooking, flying, and exploring the outdoors.


 Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer,
Dakota Biotech


Maya Ivanjesku M.S. is a creative visionary, CSO and a formulation scientist at Dakota Biotech -The Live Probiotic Skincare company. With over 25 years of experience in developing products for the beauty industry, Maya is a formulation expert. Her career path started at Estee Lauder Companies where she was formulating products for Estee Lauder, Clinique, Origins, Bobby Brown, Aveda, LaMer etc. With her passion for science and nature, Maya also ventured into Biotech, OTC and topical Rx and Medical Device formulation and developed topical prescription formulas for numerous pharmaceutical companies. The diversity of her career path in formulating products, overseeing manufacturing, R&D and holding executive positions in numerous industries from cosmetic to pharmaceutical and biotech product launches, has lead Maya into an entrepreneurial opportunity at Dakota Biotech where LaFloreÒ Probiotic Skincare product line was born. Maya’s passion for wellness, education and helping people heal – naturally, is the main driver in developing performance focused products.


Peter Leighton
Peter Leighton
CEO,
ProSperity Bioscience


Peter Leighton is the CEO of ProSperity Bioscience, engaged in the development and marketing of functionally targeted probiotic consumer products. Leighton is also the founder of Abunda, an integrated consulting practice. His 30+ years of executive experience at the intersection of consumer products and life science technology has leveraged emerging scientific research & discovery into engaging consumer brands. He has identified and executed novel marketing & commercialization strategies leading to the successful development and launch of hundreds of new products. Leighton has been a guiding light to entrepreneurial enterprises and companies facing a challenge. In the early 2000’s he orchestrated a 300% increase in stock valuation and sales growth at Natrol (NTOL). Leighton has held senior executive positions including VP Product Strategy at Complete Nutrition, CEO at Advana Science, VP Marketing & Product Development at Natrol (NTOL), Vice President at Galileo Laboratories, VP Marketing at Metabolife, SVP Marketing at Weider Nutrition (WNI) and Director of Marketing at InterHealth Nutraceuticals.


Seth D. Crosby
Seth D. Crosby
Director, Research Collaborations,
Washington University School of Medicine



Arun K. Bhunia
Arun K. Bhunia
Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science,
Purdue Institute of Inflammation, Immunology and Infectious Disease



 Emily Stein
Emily Stein
CEO,
Primal Health Inc.


Ph.D. founded Primal Health, LLC in 2017 to focus on improving the dental health of both humans and animals by producing oral microbiome modulation products. She has spent 12 years developing SMMRT technology at Primal Therapies, Inc., which is focused on using metabolic influencers to re-engineer disease-causing bacterial biofilms into those that are health-promoting, to decrease inflammation and to improve outcomes. Prior to that, she spent 7 years as a research fellow at Stanford University in Rheumatology and Immunology focused on the neuro-endocrine-immune axis in autoimmune and chronic inflammatory diseases. She holds a Ph.D. in Microbiology from the University of California at Berkeley where she studied inter- and intra-cellular signaling pathways involved in stress response and community development in bacteria and received her B.S. in Microbiology and Immunology at the University of Iowa where she studied the interaction between M. tuberculosis and innate immune cells.


 Nicole M. Scott
Nicole M. Scott
CEO and Founder,
Cybele Microbiome


Nicole is a domain expert in the microbiome and data science who has spent the last 6 years in startups doing everything from marketing, business strategy, IP, data analysis, and fundraising. She studied at the University of Michigan and University of Chicago with Dr. Jack Gilbert, and was the first employee at Dr. Rob Knight’s microbiome startup Biota. She is cited more than 2000 times, published in prestigious journals such as Science and Nature, and is the author of several book chapters and patents. She also serves as an advisor to several other life science and biotech startups.


Yug Varma
Yug Varma
CEO,
Phi Therapeutics


Yug Varma, PhD, is the cofounder and CEO of Phi Therapeutics, a venture-backed microbiome company focused on skin disorders based in San Francisco. He has an extensive background in bio-organic chemistry, microbiology, synthetic biology, and microbiome research. Yug received

his scientific training at several distinguished academic institutions, including Johns Hopkins University (PhD) and University of California, San Francisco


Larry Weiss
Larry Weiss
CEO & Founder,
Symbiome


Larry Weiss is the CEO and Founder of Weiss Bioscience, Inc., a San Franciscobased microbiome research and development company and the manufacturer of Symbiome Skincare products.


Leigh A. Frame
Leigh A. Frame
Associate Director, Resiliency & Well-being Center,
Program Director, Integrative Medicine (INTM), Executive Director, Office of INTM & Health



Scott A. Jackson
Scott A. Jackson
Leader – Complex Microbial Systems Group,
NIST - National Institute of Standards and Technology



Andrea Azcarate-Peril
Andrea Azcarate-Peril
Associate Professor of Medicine, Director,
UNC Microbiome Core, School of Medicine, University of North Carolina at Chapel Hill